The authors reply

New England Journal of Medicine

Volumn 369, Issue 19, 2013, Pages 1860-1861

  Suthanthiran, Manikkam ^a   Muthukumar, Thangamani ^a   Schwartz, Joseph E ^b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; INTERLEUKIN 2 RECEPTOR ALPHA; MESSENGER RNA; RNA 18S; TRANSCRIPTION FACTOR FOXP3; GAMMA INTERFERON INDUCIBLE PROTEIN 10; RIBOSOME RNA; SIGNAL PEPTIDE;

ACUTE GRAFT REJECTION; ANALYTICAL PARAMETERS; BK VIRUS INFECTION; BOOTSTRAPPING; CALIBRATION; CELLULAR IMMUNITY; CREATININE BLOOD LEVEL; GENETIC ASSOCIATION; GRAFT RECIPIENT; HUMAN; KIDNEY BIOPSY; KIDNEY GRAFT REJECTION; LETTER; PRACTICE GUIDELINE; PREDICTIVE VALUE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RNA ANALYSIS; FEMALE; GENETICS; GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; NOTE; URINE;

CHEMOKINE CXCL10; FEMALE; GRAFT REJECTION; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KIDNEY TRANSPLANTATION; MALE; RNA, MESSENGER; RNA, RIBOSOMAL;

EID: 84887118568     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1310006     Document Type: Letter

References (5)

1. Dadhania D, Snopkowski C, Ding R, et al. Validation of noninvasive diagnosis of BK virus nephropathy and identification of prognostic biomarkers. Transplantation 2010;90:189-97.
2. Steyerberg EW, Vickers AJ, Cook NR, et al. Assessing the performance of prediction models: a framework for traditional and novel measures. Epidemiology 2010;21:128-38.
3. Bustin SA, Benes V, Garson JA, et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 2009;55:611-22.
4. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 2008;3:1101-8.
5. Røge R, Thorsen J, Tørring C, Ozbay A, Møller BK, Carstens J. Commonly used reference genes are actively regulated in in vitro stimulated lymphocytes. Scand J Immunol 2007;65:202-9.